Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

Medical treatments can help manage frontal fibrosing alopecia, but hair transplantation should be done cautiously and only if the disease is inactive.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Treating hair loss in PCOS involves a combination of lifestyle changes, medication, and possibly hair care strategies.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.